期刊文献+

双柏散外敷合四君子汤加减对胃癌化疗患者消化道不良反应、生活质量及静脉炎发生率的影响 被引量:2

Influence of External Application of Shuangbai Powder Combined with Modified Sijunzi Decoction on Gastrointestinal Adverse Reactions,Quality of Life and Incidence of Phlebitis in Patients with Gastric Cancer Undergoing Chemotherapy
下载PDF
导出
摘要 目的:探讨双柏散外敷合四君子汤加减对胃癌化疗患者消化道不良反应、生活质量及静脉炎发生率的影响。方法:选取2019年3月-2022年3月东台市中医院收治的胃癌化疗患者82例,按照随机数字表法分两组,对照组予以常规化疗,观察组在对照组基础上予以双柏散外敷合四君子汤加减治疗。评估临床疗效、中医症候积分及生活质量,并记录不良反应及静脉炎发生情况。结果:治疗3个月后,观察组临床总有效率60.98%高于对照组的41.46%,差异有统计学意义(P<0.05);观察组胃脘胀痛、食少纳差、倦怠乏力、大便异常及恶心呕吐等中医症候积分均明显低于对照组,差异均有统计学意义(P<0.05);观察组胃肠道反应、静脉炎发生率均比对照组低,差异均有统计学意义(P<0.05);两组肝、肾功能损伤及周围神经毒性发生率比较差异均无统计学意义(P>0.05)。治疗3个月后,观察组胃癌患者生活质量问卷(QLQ-STO_(2)2)评分明显低于对照组,差异有统计学意义(P<0.05)。结论:双柏散外敷合四君子汤加减用于胃癌化疗效果显著,能够促进症状改善,减轻消化道不良反应,降低静脉炎发生率,同时还能提高生活质量,可供临床参考应用。 Objective:To investigate the effect of external application of Shuangbai Powder combined with modified Sijunzi Decoction on gastrointestinal adverse reactions,quality of life and incidence of phlebitis in patients with gastric cancer undergoing chemotherapy.Method:A total of 82 patients with gastric cancer treated in Dongtai Hospital of Traditional Chinese Medicine from March 2019 to March 2022 were selected and divided into two groups according to the random number table method.The control group received conventional chemotherapy,and the observation group received external application of combined with modified Sijunzi Decoction on the basis of the control group.The clinical efficacy,TCM symptom score and quality of life were evaluated,and adverse reactions and phlebitis were recorded.Result:After 3 months of treatment,the total clinical effective rate of the observation group was 60.98%,higher than 41.46%of the control group,the difference was statistically significant(P<0.05);the TCM syndrome scores such as epigastric pain,lack of appetite,fatigue,abnormal stool,nausea and vomiting in the observation group were significantly lower than those in the control group,the differences were statistically significant(P<0.05);the incidences of gastrointestinal reaction and phlebitis were lower than those of the control group,the differences were statistically significant(P<0.05);there were no significant differences in the incidences of liver and kidney damage and peripheral neurotoxicity between the two groups(P>0.05).After 3 months of treatment,the quality of life questionnaire of stomach 22(QLQ-STO_(2)2)score of the observation group was significantly lower than that of the control group,the difference was statistically significant(P<0.05).Conclusion:External application of Shuangbai Powder combined with modified Sijunzi Decoction has significant curative effect on gastric cancer chemotherapy,which can improve symptoms,reduce adverse reactions of digestive tract,reduce the incidence of phlebitis,and improve the quality of life at the same time,which can be used for clinical reference application.
作者 徐娴 崔德利 黄小兵 XU Xian;CUI Deli;HUANG Xiaobing(Dongtai Hospital of Traditional Chinese Medicine,Jiangsu Province,Dongtai 224200,China;不详)
出处 《中国医学创新》 CAS 2023年第6期61-65,共5页 Medical Innovation of China
关键词 胃癌 化疗 双柏散外敷 四君子汤加减 消化道不良反应 生活质量 静脉炎 Gastric cancer Chemotherapy External application of Shuangbai Powder Modified Sijunzi Decoction Adverse reactions of digestive tract Quality of life Phlebitis
  • 相关文献

参考文献14

二级参考文献131

  • 1胃癌诊疗规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(5):62-71. 被引量:246
  • 2陈国志,傅东.加味四君子汤对8 Gy照射大鼠小肠移行性肌电复合波的影响[J].中国中西医结合杂志,1996,16(4):221-223. 被引量:3
  • 3WHO handbook for reporting results of cancer treatment [M].Geneva (Switzerland):World Health Organization,1979.
  • 4Duffaud F,Therasse P.New guidelines to evaluate the response to treatment in solid tumors[J].Bull Cancer,2000,87(12):869-870.
  • 5James K,Eisenhauer E,Christian M,et al.Measuring response in solid tumors:unidimensional versus bidimensional measurement[J].J Natl Cancer Inst,1999,91(6):523-528.
  • 6Mazumdar M,Smith A,Schwartz LH.A statistical simulation study finds discordance between WHO criteria and RECIST guideline[J].J Clin Epidemiol,2004,57(4):358-365.
  • 7Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors [J].J Natl Cancer Inst,2000,92(3):179-181.
  • 8Werner-Wasik M,Xiao Y,Pequignot E,et al.Assessment of lung cancer response after nonoperative therapy:tumor diameter,bidimensional product,and volume.A serial CT sean-based study[J].Int J Radiat Oncol Biol Phys,2001,51(1):56-61.
  • 9Prasad SR,Saini S,Sumner JE,et al.Radiological measurement of breast cancer metastases to lung and liver:comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines [J].J Comput Assist Tomogr,2003,27(3):380-384.
  • 10Trillet-Lenoir V,Freyer G,Kaemmerlen P,et al.Assessment of tumour response to chemotherapy for metastatic coloreetal cancer:accuracy of the RECIST criteria[J].BrJ Radiol,2002,75(899):903-908.

共引文献308

同被引文献33

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部